• Images
• Videos
• Documents
• Books
• Articles

Founding

In 1982, the United Nations Industrial Development Organization (UNIDO) offered grant funding via a competitive application process to facilitate biotechnology development in the Third World.¹: 132  Cuba sought, but did not receive funding, which instead was awarded to a joint project proposed by India and Italy.²: 132  Cuba nonetheless proceeded with the development of a biotechnology research institution using its own funds, CIGB.³: 132 

Activity

In 2006, CIGB developed the Heberprot-P, which is used to treat foot ulcers.⁴ Its use results in rapid wound healing and a 75% decrease in amputations among diabetics with foot ulcers.⁵

As of 2017, CIGB had 1,600 employees and sold 21 products internationally.⁶: 138 

As of 2020, CIGB had two joint ventures with China.⁷: 143 

It is responsible for creating the Abdala vaccine.⁸⁹¹⁰

The Centre developed the COVID-19 vaccine Mambisa, which is in the final stages of clinical trials.¹¹

See also

• BioCubaFarma
• Center of Molecular Immunology

External links

• Official website

References

1. Yaffe, Helen (2020). We Are Cuba! How a Revolutionary People Have Survived in a Post-Soviet World (hardcover ed.). USA: Yale University Press. ISBN 978-0-300-23003-1. 978-0-300-23003-1 ↩

2. Yaffe, Helen (2020). We Are Cuba! How a Revolutionary People Have Survived in a Post-Soviet World (hardcover ed.). USA: Yale University Press. ISBN 978-0-300-23003-1. 978-0-300-23003-1 ↩

3. Yaffe, Helen (2020). We Are Cuba! How a Revolutionary People Have Survived in a Post-Soviet World (hardcover ed.). USA: Yale University Press. ISBN 978-0-300-23003-1. 978-0-300-23003-1 ↩

4. "UA Health Sciences Researchers Look to Collaborate With Cuba on Diabetic Wound Therapy | Department of Medicine". deptmedicine.arizona.edu. Retrieved 2023-12-27. https://deptmedicine.arizona.edu/news/2016/ua-health-sciences-researchers-look-collaborate-cuba-diabetic-wound-therapy ↩

5. "UA Health Sciences Researchers Look to Collaborate With Cuba on Diabetic Wound Therapy | Department of Medicine". deptmedicine.arizona.edu. Retrieved 2023-12-27. https://deptmedicine.arizona.edu/news/2016/ua-health-sciences-researchers-look-collaborate-cuba-diabetic-wound-therapy ↩

6. Yaffe, Helen (2020). We Are Cuba! How a Revolutionary People Have Survived in a Post-Soviet World (hardcover ed.). USA: Yale University Press. ISBN 978-0-300-23003-1. 978-0-300-23003-1 ↩

7. Yaffe, Helen (2020). We Are Cuba! How a Revolutionary People Have Survived in a Post-Soviet World (hardcover ed.). USA: Yale University Press. ISBN 978-0-300-23003-1. 978-0-300-23003-1 ↩

8. "Cuba's COVID vaccine rivals BioNTech-Pfizer, Moderna". DW.COM. 2021-06-27. Retrieved 2021-06-28. https://www.dw.com/en/cubas-covid-vaccine-rivals-biontech-pfizer-moderna/a-58052365 ↩

9. "ABDALA Clinical Study - Phase III". rpcec.sld.cu. Registro Público Cubano de Ensayos Clínicos. Archived from the original on 2021-03-20. Retrieved March 22, 2021. https://rpcec.sld.cu/en/trials/RPCEC00000359-En ↩

10. "ABDALA Clinical Study". rpcec.sld.cu. Registro Público Cubano de Ensayos Clínicos. Archived from the original on 2021-01-22. Retrieved March 22, 2021. https://rpcec.sld.cu/en/trials/RPCEC00000346-En ↩

11. Sánchez, Liz Conde (7 April 2022). "How is Mambisa progressing on the road to authorization as an anti-COVID-19 vaccine?". en.granma.cu. Retrieved 6 May 2022. https://en.granma.cu/cuba/2022-04-07/how-is-mambisa-progressing-on-the-road-to-authorization-as-an-anti-covid-19-vaccine ↩